(VCBeat) Aug. 09, 2021 -- Meio CadiNav Medical, a robotics company for interventional cardiovascular surgery, has closed on a Pre-Series A financing package. The proceeds will be used to build a cleanroom system compliant with GMP and promote clinical trials of the "Titian" robot for navigation in cardiac electrophysiology.
This round of financing is invested by TusStar, with Mingxi Capital acting as the exclusive financial advisor for the transaction.
Meio CadiNav Medical was founded in June 2018 by Dr. Chen Yuemeng and Professor Lu Caiyi, director of the Department of Cardiology, 301 Hospital. Meio CadiNav Medical is committed to the research and development of surgical navigation techniques and interventional surgical robots in the department of cardiology, as well as the development of magnetic navigation platform and consumable product for magnetically guiding in cardiac surgery. The company has established a research and development barrier based on its own intellectual property rights. It has obtained 27 patents and filed for 47 patent applications. It has self-developed the "Titian" robot and the "Raphaello" surgical robot – a flexible magnetic navigation stereopositioning and precision ablation system.
Meio CadiNav Medical is headquartered in Shaoxing, Zhejiang province, with core research and development centers in Shanghai, Hangzhou and Shaoxing. In the first half of 2021, Meio CadiNav Medical has successfully completed animal experiments of "Titian".
Since its inception, Meio CadiNav Medical has been committed to becoming a leader in Robotic cardiac surgery, developing intelligent cath lab surgical solutions, and winning recognition from society.
Founded in 1999 and headquartered in Beijing, China, TusStar is an investment firm that integrates innovation services and building business platforms. The company has incubated over 5000 firms, among which are excellent companies, including 49 Diamond Companies, 45 Golden Seed Project companies, and 34 listed companies as well as great entrepreneurs including 81 leading talents from RecruitmentProgram of Global Experts, Overseas Talent Pooling Program, and High-end Leading Talent Pooling Program.